Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

QR Code

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

Michael A Singer,1 Steven R Cohen,2 Sylvia L Groth,3 Salman Porbandarwalla21Medical Center Ophthalmology Associates (MCOA), San Antonio, Texas, USA; 2Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA; 3University of Minnesota Medical Schoo...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Singer MA, Cohen SR, Groth SL, Porbandarwalla S
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/da4a9277206a42c9bea4f22a7cc3547e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Retinal vein occlusion and macular edema &ndash; critical evaluation of the clinical value of ranibizumab
par: Keane PA, et autres
Publié: (2011)

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
par: Eltutar K, et autres
Publié: (2013)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
par: Juan Carlos Mesa Guti&eacute;rrez, et autres
Publié: (2008)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
par: Ivanovska Adjievska B, et autres
Publié: (2017)

Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
par: Narayanan R, et autres
Publié: (2016)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
par: Thapa R, et autres
Publié: (2012)

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
par: Demir M, et autres
Publié: (2011)

Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
par: Ogino K, et autres
Publié: (2011)

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
par: Gokce G, et autres
Publié: (2014)

Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion
par: Sakaguchi H, et autres
Publié: (2012)

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
par: Dogan E, et autres
Publié: (2018)

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
par: Mushtaq B, et autres
Publié: (2014)

Microvascular Structure Changes After Intravitreal Ranibizumab Injection in Retinal Vein Occlusion Patients With and Without Macular Ischemia
par: Ziyi Zhu, et autres
Publié: (2021)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
par: Yalamanchi S, et autres
Publié: (2011)

Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
par: Hirose M, et autres
Publié: (2014)

Vitrectomy for macular edema due to retinal vein occlusion
par: Kumagai K, et autres
Publié: (2019)

Treatment of macular edema due to retinal vein occlusions
par: Channa R, et autres
Publié: (2011)

OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion
par: Kwang-Eon Choi, et autres
Publié: (2019)

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
par: Kartasasmita AS, et autres
Publié: (2016)

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
par: Ito Y, et autres
Publié: (2015)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
par: Callizo J, et autres
Publié: (2019)

The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients
par: Toshinori Murata, et autres
Publié: (2021)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
par: Kumagai K, et autres
Publié: (2019)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
par: Tsai MJ, et autres
Publié: (2018)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Comparative analysis of the development of collateral vessels in macular edema due to branch retinal vein occlusion following grid laser or ranibizumab treatment
par: Kokolaki AE, et autres
Publié: (2015)

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
par: Saquib Naeem, et autres
Publié: (2019)

Peripapillary retinal nerve fiber layer thickness in patients with unilateral retinal vein occlusion
par: Jayoung Ahn, et autres
Publié: (2021)

Relationship between metamorphopsia and inner retinal microstructure following intravitreal ranibizumab injection for branch retinal vein occlusion
par: Yoshimi Sugiura, et autres
Publié: (2021)

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2016)

Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients
par: Toshinori Murata, et autres
Publié: (2021)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
par: Tagami M, et autres
Publié: (2017)

A patient with acute macular neuroretinopathy and central retinal vein occlusion
par: Hirooka K, et autres
Publié: (2013)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
par: Udaondo P, et autres
Publié: (2011)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
par: Paulose R, et autres
Publié: (2016)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
par: Hall J
Publié: (2016)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
par: Sivaprasad S, et autres
Publié: (2016)

One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK
par: Lip PL, et autres
Publié: (2015)

Changes in peripapillary and subfoveal choroidal thickness in patients with central retinal vein occlusion.
par: Hae Min Kang, et autres
Publié: (2021)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
par: Tagami M, et autres
Publié: (2017)